All In MedTech

Device Trial Radar · NCT06910592

EXOMIND (BTL-995) for Reduction of Binge-eating

Safety and Efficacy of the BTL-995-rTMS Device for the Reduction of Binge-eating

Last checked: Nov 19, 2026Latest source record: Sep 17, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

23

Actual

Start

Jul 26, 2023

Primary completion

Dec 15, 2023

Study completion Mar 11, 2024

Sponsor

Lead sponsor
BTL Industries Ltd.Not on our public-company list
Sponsor type
Industry
First posted
Apr 4, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 22 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The goal of this clinical trial is to evaluate if the treatment with the BTL-995-rTMS device is able to reduce binge eating in adults above the age of 22 years. The main question it aims to answer is: Whether the treatment with the BTL-995-rTMS device reduces binge eating. Participants will be asked to: Undergo six treatments Undergo weight measurements Complete the Binge Eating Scale Complete the Therapy Comfort Questionnaire Complete the Satisfaction Questionnaire

Conditions

  • Binge-Eating Disorder

Interventions

  • Treatment with BTL-995-rTMSDevice

    Six transcranial magnetic stimulation treatments with the BTL-995-rTMS device will be delivered over the left dorsolateral prefrontal cortex, spaced 2 to 4 days apart. The intensity will be adjusted according to the subject's feedback, up to 70% of the individual's motor threshold.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Assessment of Change in Binge EatingTime frame: 3 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Medical Center "Intermedica"

    Sofia, Bulgaria

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.